Skip to main content
. 2009 Oct 21;34(1):3–12. doi: 10.1007/s00264-009-0892-0

Table 1.

The effectiveness of bone marrow (BM) injections for nonunions

First author/year Number of nonunions Type Mean age (y), n (range) United, n (%) Time to union (months), n (range) Comments
Healey/1990 [45] 8 Femur 8 27 (6–60) 5 (62.5) 4.95 (1–9) Nonunion occurred after reconstruction for lower limb cancer resection
50 ml percutaneous injection
Connolly/1991 [18] 10 Tibia 10 30 (18–82) 8 (80) 6.7 (5–10) 100–150 ml of BM aspirated and injected
Fractures were immobilised by cast
Garg/1993 [32] 20 Tibia 15 35 (18–65) 17 (85) 5 (3–7) Percutaneous injection of 15–20 ml of BM
Humerus 3
Ulna 2
Sim/1993 [102] 11 Tibia 8 38 (19–62) 9 (81) 2.5 (1–5.75) Percutaneous injection of 50–200 ml of BM
Femur 1
Humerus 1
Ulna 1
Garg/1995 [33] Case report Tibia 12 1 (100) 18 ∼20 ml of BM were aspirated and injected in pseudoarthrosis while limb was placed in cast
After 3 weeks the procedure was repeated
Matsuda/1998 [69] 7 Femur 53 (24–70) 4 (57) na (5–9) Percutaneous technique with injection of 150 ml of BM
Two infections encountered resulting in failed union
Sebecic/1999 [99] Case report Tibia 1 44 1 (100) 5 150 ml injected and immobilisation achieved by external fixation
Siwach/2001 [103] 72 Tibia 42 41.2 (26–56) 68 (94) na A maximum of 30 ml of BM aspirated and injected percutaneously at nonunion site
Femur 8 The procedure was repeated where required after 4–6 weeks after initial injection
Humerus 12
Forearm 10
Wang/2001 [113] 56 Tibia na (19–72) 53 (94) na BM aspirated and injected percutaneously at nonunion site
The procedure was repeated every month 2–3 times
Wilkins/2003 [115] 69 Tibia 36 42 (15–81) 61 (88) 8.1 (2–36) Percutaneous technique with BM combined with allograft demineralised bone matrix
Femur 16
Humerus 4
Others 13
Goel/2005 [38] 20 Tibia 20 37.5 (24–60) 15 (75) 3.5 (1.5–5.5) A maximum of 15 ml of BM was aspirated and percutaneously injected
Hernigou/2005 [47] 60 Tibia 60 40 (18–78) 53 (88) 3 (1–4) An average of 306 ± 24 ml was aspirated, concentrated to 20 ml and percutaneously injected
Tetreault/2007 [107] Case report Clavicle 39 1 (100) na (within 12) Percutaneous injection of 10 ml of BM

na not available

Level of Evidence: All presented studies are 2C except case reports which are 1C